To help improve medicines situations for low and middle-income country populations across the world, the group leads and collaborates on major global medicines research activities.
We founded and lead the global Medicines and Insurance Coverage (MedIC) Initiative; collaborate on the development of practical, valid methods to assess medicines situations; provide technical support in the design, development, and implementation of medicines policy and other intervention research studies in health systems; and support the dissemination of global medicines research.
Please click on the links below to learn more about our recent International Research
Developing a portfolio of evidence for medicines benefit decision-making in emerging and expanding health insurance schemes.
- Generating evidence to support decisions in US and global health systems on providing access to, financing, and managing specialty medicines
Developing and refining practical, valid methods to assess all aspects of a country’s pharmaceutical sector.
Developing and refining practical, valid methods to assess medicines prices throughout the supply chain; availability in retail settings, and affordability for individuals.
Developing and implementing household surveys to assess access, affordability, use, and consumer perceptions of medicines in systems.
Assembling and sharing state-of-the art knowledge on medicines situations and the impacts of interventions to improve medicines access, affordability, and use.